CAS: 54301-15-4; N-(4-(Acridin-9-Ylamino)-3-Methoxyphenyl)Methanesulfonamide Hydrochloride

该化合物是一种主要用于治疗急性白血病的抗乳粉剂,它作为DNA间隔剂和托波异构体酶II抑制剂发挥作用,干扰快速分裂的癌症细胞的DNA复制和转录;盐盐形式提高了溶解性,便利静脉注射;主要优点包括它在耐受性或复发性白血病病例中表现出的功效,特别是在与其他乳油剂结合的情况下.它的行动机制将它与其他炭疽杆菌区分开来,为抗其他治疗的病人提供了替代方法.由于潜在的血解毒性和心脏效应,需要仔细监测.该化合物通常作为一种淋巴化的粉剂供应,用于重建,确保稳定性和精确剂量.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号1207-69-8 9-氯吖啶 | CAS号57165-06-7 N-(4-氨基-3-甲氧基苯基)甲磺酰胺 | CAS号57165-05-6 3-methoxy-4-nit... | CAS号16292-88-9 3-甲氧基-4-硝基苯胺 | CAS号20628-19-7 N-(3-甲氧基-4-硝基苯基)乙酰胺

合成工艺路线路线简述

    3-甲氧基-4-硝基苯胺置于palladium On Activated Charcoal 吡啶,盐酸,氢气体系中,用 甲醇 作为反应溶剂,20.0 °C,202.65 Kpa 条件下,反应 4.25H,反应生成 胺苯吖啶
    参考文献:Potential Antitumor Agents. 48. 3'-Dimethylamino Derivatives Of Amsacrine: Redox Chemistry And In Vivo Solid Tumor Activity
    标题:Potential Antitumor Agents. 48. 3'-Dimethylamino Derivatives Of Amsacrine: Redox Chemistry And In Vivo Solid Tumor Activity
    摘要:Structure-Activity Relationships For A Series Of Acridine-Substituted 3'-N(Ch3)2 Derivatives Of The Clinical Antileukemic Drug Amsacrine (1) Are Reported. The Parent (Unsubstituted) Compound 3 Has Activity Against The Lewis Lung Solid Tumor That Is Superior To Amsacrine (1),The New Clinical Amsacrine Analogue 4,And The Recently Developed 3'-Nhch3 Derivative 2. Although The Compounds Generally Bind Less Well To Dna And Are Less Dose Potent In Vivo Than Either Their Amsacrine (3'-och3) Or 3'-Nhch3 Analogues,They Show Very High Levels Of Antitumor Activity,With The 4-och3 Derivative Capable Of Effecting 100% Cures Of The Lewis Lung Solid Tumor. The Broad Structure-Activity Relationships For Acridine Substitution More Closely Resemble Those Of The Amsacrine Than The 3'-Nhch3 Series,With 4-Substituted And 4,5-Disubstituted Compounds Showing The Highest Activity.
    DOI:10.1021/jm00387A012

    海关参考信息

    辽宁博美医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.biosunpharm.com
    企业联系电话:024-24524889,18640309171👤
    📞辽宁博美医药科技有限公司 ⚠️参考联系方式
    联系人:李伟
    电话:024-24524889,18640309171
    手机:18640309171
    传真:024-24524889
    邮箱:sales@biosunpharm.com
    通信地址: 本溪经济开发区药都研发中心
    邮编: 110015
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:本溪经济开发区药都研发中心
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Jangir DK, Kundu S, Mehrotra R. Role of minor groove width and hydration pattern on amsacrine interaction with DNA. PLoS One. 2013 Jul 29;8(7):e69933. doi: 10.1371/journal.pone.0069933. Print 2013.
    2: Krejci M, Doubek M, Dusek J, Brychtova Y, Racil Z, Navratil M, Tomiska M, Horky O, Pospisilova S, Mayer J. Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia. Ann Hematol. 2013 Jun 1. [Epub ahead of print] doi: 10.1200/JCO.2012.46.4743. Epub 2013 Apr 29. doi: 10.3109/10428194.2012.713479. Epub 2012 Sep 8. doi: 10.1016/j.jphotobiol.2012.05.005. Epub 2012 May 18. doi: 10.1021/bi201159b. Epub 2012 Feb 10.
    7: Attia SM. Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells. J Appl Toxicol. 2013 Jun;33(6):426-33. doi: 10.1002/jat.1753. Epub 2011 Nov 11. doi: 10.3109/10428194.2011.588760. Epub 2011 Jun 24. doi: 10.1016/j.jphotobiol.2009.11.005. Epub 2009 Nov 22.

    合成参考文献


    摘要:National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program., JAN1986
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知